Toru Uchimura - Publications

Discontinuation of mycophenolate mofetil as maintenance therapy after rituximab treatment in childhood-onset complicated frequently relapsing or steroid-dependent nephrotic syndrome.

Journal: Pediatric nephrology (Berlin, Germany)

Published: February 12, 2026

Long-term outcome of mycophenolate mofetil after a single dose of rituximab in childhood-onset refractory idiopathic nephrotic syndrome.

Journal: Clinical and experimental nephrology

Published: February 01, 2025

Recovery from rituximab-associated persistent hypogammaglobulinaemia in children with nephrotic syndrome.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Published: February 09, 2024

Two adolescents with frequently relapsing nephrotic syndrome newly diagnosed after SARS-CoV-2 vaccination: case report and literature review.

Journal: CEN case reports

Published: February 06, 2024

Multinucleated podocytes as a clue to diagnosis of juvenile nephropathic cystinosis.

Journal: Pediatric nephrology (Berlin, Germany)

Published: March 30, 2023

Aggressive immunotherapy combined with bortezomib and rituximab for membranous nephropathy associated with enzyme replacement therapy in Pompe disease.

Journal: Pediatric nephrology (Berlin, Germany)

Published: April 15, 2022

Early predictive factors for progression to kidney failure in infants with severe congenital anomalies of the kidney and urinary tract.

Journal: Pediatric nephrology (Berlin, Germany)

Published: March 06, 2022

New-onset pediatric nephrotic syndrome following Pfizer-BioNTech SARS-CoV-2 vaccination: a case report and literature review.

Journal: CEN case reports

Published: September 22, 2021